RE:warrantsDJDawg wrote:
Interesting discussion about warrants. I know that I've seen PR's that warrants have been extended. Can anyone clarify, the massive load of warrants from 4 years ago....can those be extended?
I can see it going both ways. If warrants are redeemed because the stock is above 0.35, that brings in something like 20m in funds which is a win. If they are not redeemed, then 57,500,000 fewer shares out there. That would prevent the shares outstanding from jumping by 25% if I understand it correctly.
Yes they can be extended DJDawg. One minor point that I feel has been brought up many times is share dilution which with share options and warrants plus future options looking out say three years could roughly be 350 million give or take 10M.
Let's say Theralase achieve BTD before 2023 year end, followed by AA and gets a few Pharmaceutical partners (with more to join up) by end of 1stQ ok. So I believe there were in 2022 573,000 worldwide est cases of Bladder cancer patients out of which roughly 75% NMIBC and the balance 25% are MIBC. Gives us 430,000 possible patients worldwide but how many have insurance or available money to pay for treatment? Let's say 66% = 283,000 now with the Pharmaceuticals network say we grab only half of the patients = 141,500 X $300,000 = $42,450,000,000 this has to be divided by the agreement between Theralase and its partners but
point here is does it really matter if our share count is a projected 275M or 350M